Alexander Emrich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Emrich has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Alessandra Moretti
First Department of Medicine, Cardiology, Klinikum Rechts der Isar Technical University of Munich Munich Germany
1 shared publication - Ali Ertürk
Institute for Intelligent Biotechnologies (iBIO), Helmholtz Center Munich, Neuherberg, Germany
1 shared publication Andrea Bähr
Large Animal Models in Cardiovascular Research, Klinik und Poliklinik für Innere Medizin I, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
1 shared publicationAriane Krus
Institute of Developmental Genetics, Helmholtz Munich, Oberschleißheim, Germany
1 shared publicationBarbara Tremmel
Institute of Developmental Genetics, Helmholtz Munich, Oberschleißheim, Germany
1 shared publication- Brice Beinsteiner
Helmholtz Pioneer Campus, Helmholtz Munich, Oberschleissheim, Germany
1 shared publication
Latest Publications
- Open Access
- 2 September 2026
- Published by Springer Nature in Nature
- Vol. 658 (8136) , 805-813
Creating bottom-up RNA transfer vehicles from synthetic protein assemblies
Evolution guides biological systems to populate ecological niches, with viruses among the most successful examples of this principle. Viruses evolved over billions of years to efficiently transfer genetic information. Although viruses are highly diverse, most have converged towards remarkable similarity in the size and shape of their capsids 1,2 . By contrast, generative models for protein design enable the creation of protein architectures that are absent from nature 3–5 . Here we investigate whether protein assemblies designed by artificial intelligence can be functionalized to construct nucleic acid transport vehicles that are independent of evolutionary trajectories. By combining natural protein domains with synthetic protein assemblies, we create more than 100 bottom-up RNA transfer vehicles with unique sizes and shapes. These vehicles surpass the RNA transfer efficiency of widely used delivery vehicles by several orders of magnitude. In addition, we demonstrate that their tropism can be programmed by incorporation of computationally designed peptide binders and use them to deliver therapeutically relevant cargo RNAs into a wide range of cellular models. We show the in vivo biodistribution of one of these vehicles in a mouse at near-single-cell resolution, confirm its safety, and use it to perform a gene-editing treatment strategy for Duchenne muscular dystrophy in patient-derived cells and a pig. Our work demonstrates how proteins created by generative artificial intelligence can be harnessed for the rational engineering of RNA transport systems with the desired properties by overcoming the limitations of natural protein diversity.
- 2 September 2026
- Published by Springer Nature in Nature
- Vol. 658 (8136) , 805-813
Open AccessCreating bottom-up RNA transfer vehicles from synthetic protein assemblies
Evolution guides biological systems to populate ecological niches, with viruses among the most successful examples of this principle. Viruses evolved over billions of years to efficiently transfer genetic information. Although viruses are highly diverse, most have converged towards remarkable similarity in the size and shape of their capsids 1,2 . By contrast, generative models for protein design enable the creation of protein architectures that are absent from nature 3–5 . Here we investigate whether protein assemblies designed by artificial intelligence can be functionalized to construct nucleic acid transport vehicles that are independent of evolutionary trajectories. By combining natural protein domains with synthetic protein assemblies, we create more than 100 bottom-up RNA transfer vehicles with unique sizes and shapes. These vehicles surpass the RNA transfer efficiency of widely used delivery vehicles by several orders of magnitude. In addition, we demonstrate that their tropism can be programmed by incorporation of computationally designed peptide binders and use them to deliver therapeutically relevant cargo RNAs into a wide range of cellular models. We show the in vivo biodistribution of one of these vehicles in a mouse at near-single-cell resolution, confirm its safety, and use it to perform a gene-editing treatment strategy for Duchenne muscular dystrophy in patient-derived cells and a pig. Our work demonstrates how proteins created by generative artificial intelligence can be harnessed for the rational engineering of RNA transport systems with the desired properties by overcoming the limitations of natural protein diversity.